BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20573638)

  • 1. Calculating sample size in trials using historical controls.
    Zhang S; Cao J; Ahn C
    Clin Trials; 2010 Aug; 7(4):343-53. PubMed ID: 20573638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size calculation for studies comparing binary outcomes using historical controls.
    Zhang S; Cao J; Ahn C
    Biom J; 2013 Mar; 55(2):190-202. PubMed ID: 23335222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size considerations for historical control studies with survival outcomes.
    Zhu H; Zhang S; Ahn C
    J Biopharm Stat; 2016; 26(4):657-71. PubMed ID: 26098200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uniform power method for sample size calculation in historical control studies with binary response.
    Lee JJ; Tseng C
    Control Clin Trials; 2001 Aug; 22(4):390-400. PubMed ID: 11514040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival trial design and monitoring using historical controls.
    Wu J; Xiong X
    Pharm Stat; 2016 Sep; 15(5):405-11. PubMed ID: 27307025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small sample performance of bias-corrected sandwich estimators for cluster-randomized trials with binary outcomes.
    Li P; Redden DT
    Stat Med; 2015 Jan; 34(2):281-96. PubMed ID: 25345738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample Size Calculation: Inaccurate A Priori Assumptions for Nuisance Parameters Can Greatly Affect the Power of a Randomized Controlled Trial.
    Tavernier E; Giraudeau B
    PLoS One; 2015; 10(7):e0132578. PubMed ID: 26173007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls.
    Yuan J; Liu J; Zhu R; Lu Y; Palm U
    J Biopharm Stat; 2019; 29(3):558-573. PubMed ID: 30612514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of sample size and bias on the reliability of estimates of error: a comparative study of Dahlberg's formula.
    Springate SD
    Eur J Orthod; 2012 Apr; 34(2):158-63. PubMed ID: 21447784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An imbalance in cluster sizes does not lead to notable loss of power in cross-sectional, stepped-wedge cluster randomised trials with a continuous outcome.
    Kristunas CA; Smith KL; Gray LJ
    Trials; 2017 Mar; 18(1):109. PubMed ID: 28270224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.
    Smith CL; Thomas Z; Enas N; Thorn K; Lahn M; Benhadji K; Cleverly A
    Pharm Stat; 2020 May; 19(3):276-290. PubMed ID: 31903699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of sequentially randomized trials for testing adaptive treatment strategies.
    Ogbagaber SB; Karp J; Wahed AS
    Stat Med; 2016 Mar; 35(6):840-58. PubMed ID: 26412033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blinded sample size recalculation in clinical trials incorporating historical data.
    Hees K; Kieser M
    Contemp Clin Trials; 2017 Dec; 63():2-7. PubMed ID: 28735110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inference and sample size calculation for clinical trials with incomplete observations of paired binary outcomes.
    Zhang S; Cao J; Ahn C
    Stat Med; 2017 Feb; 36(4):581-591. PubMed ID: 27862151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
    Brard C; Hampson LV; Gaspar N; Le Deley MC; Le Teuff G
    BMC Med Res Methodol; 2019 Apr; 19(1):85. PubMed ID: 31018832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blinded continuous monitoring in clinical trials with recurrent event endpoints.
    Friede T; Häring DA; Schmidli H
    Pharm Stat; 2019 Jan; 18(1):54-64. PubMed ID: 30345693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size planning with the cost constraint for testing superiority and equivalence of two independent groups.
    Guo JH; Chen HJ; Luh WM
    Br J Math Stat Psychol; 2011 Nov; 64(3):439-61. PubMed ID: 20704777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Goldilocks Design with strict type I error control in confirmatory clinical trials.
    Zhan T; Zhang H; Hartford A; Mukhopadhyay S
    J Biopharm Stat; 2020 Sep; 30(5):821-833. PubMed ID: 32297825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive adjustment of the randomization ratio using historical control data.
    Hobbs BP; Carlin BP; Sargent DJ
    Clin Trials; 2013; 10(3):430-40. PubMed ID: 23690095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.